| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5897243 | Cytokine | 2013 | 7 Pages |
Neonates possess a relatively “naive”, yet inducible immune system. Our hypothesis is that upon strategic antigen exposure, cytokine priming and sensitization by accessory cells, natural killer (NK) cells could be activated to become a functional phenotype. We investigated the in vitro stimulation of cord blood (CB) and adult NK cells upon challenge with lipoteichoic acid (LTA), interleukin (IL)-15 and LTA-primed autologous macrophage-conditioned medium, using CD107a and CD69 phenotypes as indicators of activation. We also examined response of CB macrophages to LTA, in terms of P44/42 extracellular signal-regulated kinases (ERK1/2) activation and cytokine secretion. LTA significantly induced secretion of inflammatory cytokines tumor necrotic factor (TNF)-α, IL-6, IL-12 and activated the upstream signal of ERK1/2 phosphorylation in neonatal macrophages. The magnitude of responses to stimulation differed between neonatal and adult NK cells. Co-stimulation with IL-15 was critical for expansion of the CD69 and CD107a NK subpopulations in both neonatal and adult cells, upon a LTA challenge. NK cell activation could be enhanced by LTA-primed autologous macrophages through secretory factors. Our results indicated that neonatal macrophages and NK cells can evoke immunologic responses to a Gram-positive bacterial antigen. The combinatory priming strategy is relevant for development of novel protocols, such as IL-15 treatment, to compensate for the immaturity of the innate immune system in newborns against bacterial infections.
⺠LTA induces TNF-α, IL-6, IL-12 and activated ERK1/2 in neonatal macrophages. ⺠IL-15 and LTA co-stimulate CD69 and CD107a expressions on neonatal and adult NK cells. ⺠NK cell activation is enhanced by LTA-primed macrophages through secretory factors. ⺠Magnitude of responses to stimulation differs between neonatal and adult NK cells. ⺠Combinatory priming strategy could compensate immaturity of the innate immune system.
